Keyphrases
Infective Endocarditis
100%
COVID-19
96%
Denmark
66%
Copenhagen
58%
Confidence Interval
43%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
41%
Heart Failure
40%
Endocarditis
38%
All-cause Mortality
36%
Emergency Department
36%
Pregnancy-associated Plasma protein-A (PAPP-A)
32%
Triage
30%
ST-elevation Myocardial Infarction (STEMI)
29%
Hazard Ratio
28%
Echocardiography
28%
Vaccination
27%
Myocardial Infarction
26%
Risk Factors
26%
High Risk
26%
Cardiac Troponin
25%
Chronic Obstructive Pulmonary Disease
24%
Hemodialysis
24%
Left Ventricular Function
24%
BNT162b2 Vaccine
24%
Acute Coronary Syndrome
22%
Odds Ratio
22%
Risk Stratification
21%
Receptor-binding Domain
21%
Troponin
21%
Left Ventricular Ejection Fraction
21%
BNT162b2
19%
Healthcare Workers
18%
Mortality Prediction
18%
Seroprevalence
18%
Hs-cTnT
18%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
18%
Prognostic Value
18%
Placebo
17%
Neonate
17%
COVID-19 Vaccine
17%
Humoral Immune Response
17%
Coronary Artery Disease
17%
Plasma Concentration
16%
Randomized Controlled Trial
16%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
16%
High-sensitivity Cardiac Troponin
16%
SARS-CoV-2 Antibodies
16%
Vaccine Response
16%
Echocardiographic
16%
Cluster Randomized Trial
15%
Medicine and Dentistry
Infective Endocarditis
66%
Severe Acute Respiratory Syndrome Coronavirus 2
56%
Neonatal Infant
52%
Infection
47%
Heart Failure
47%
Prevalence
42%
Cohort Analysis
38%
Emergency Department
37%
Echocardiography
33%
Biological Marker
33%
Urokinase Receptor
31%
Disease
27%
COVID-19
27%
Triage
25%
Pregnancy-Associated Plasma Protein A
24%
Childbirth
21%
Risk Stratification
21%
Endocarditis
20%
Coronary Artery Disease
20%
Troponin T
19%
Heart Left Ventricle Ejection Fraction
19%
Placebo
19%
All Cause Mortality
17%
Outpatient
17%
Hazard Ratio
17%
Symptom
17%
Neonate
17%
Acute Coronary Syndrome
16%
Electrocardiogram
16%
Randomized Controlled Trial
16%
Chronic Obstructive Pulmonary Disease
15%
Cardiac Troponin
15%
ST Segment Elevation Myocardial Infarction
15%
Diagnosis
13%
Cardiac Magnetic Resonance Imaging
12%
Hemodialysis
12%
Odds Ratio
12%
Systolic Heart Failure
12%
Heart Function
11%
Gestational Age
11%
Clinical Assessment
11%
Heart Disease
10%
Prospective Cohort Study
10%
Cardiac Dysrhythmia
10%
Heart Surgery
10%
Troponin I
10%
Cardiovascular Disease
10%
Randomized Clinical Trial
9%
Cellular Immunity
9%
Diastolic Dysfunction
9%
